Prevention of viral hepatitis in HIV co-infection

被引:18
作者
Brook, G [1 ]
机构
[1] Cent Middlesex Hosp, Patrick Clements Clin, London NW10 7NS, England
关键词
hepatitis; HIV; prevention; vaccination; counselling;
D O I
10.1016/j.jhep.2005.11.022
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Co-infection of HIV-positive patients with hepatitis viruses worsens the long-term prognosis and this is summative for each new infection in any individual. Vaccination against hepatitis A or B may be effective but response rates are reduced in HIV infected patients. Improvement in response can be induced through extra doses, higher doses and HAART-induced increase in the CD4 count. Hepatitis B and C may also be prevented through counselling about safer sex, particularly condom use. In intravenous drug users, harm reduction, counselling and the use of needle/syringe exchange schemes may be helpful. (c) 2005 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:S104 / S107
页数:4
相关论文
共 36 条
[1]   Legal access to needles and syringes/needle exchange programmes versus HIV counselling and testing to prevent transmission of HIV among intravenous drug users - A comparative study of Denmark, Norway and Sweden [J].
Amundsen, EJ ;
Eskild, A ;
Stigum, H ;
Smith, E ;
Aalen, OO .
EUROPEAN JOURNAL OF PUBLIC HEALTH, 2003, 13 (03) :252-258
[2]  
Bell A, 2001, Commun Dis Public Health, V4, P163
[3]  
BHAVE G, 1995, AIDS, V9, pS21
[4]   Case fatality rate of acute viral hepatitis in Italy: 1995-2000. An update [J].
Bianco, E ;
Stroffolini, T ;
Spada, E ;
Szklo, A ;
Marzolini, F ;
Ragni, P ;
Gallo, G ;
Balocchini, E ;
Parlato, A ;
Sangalli, M ;
Lopalco, PL ;
Zotti, C ;
Mele, A ;
SEIEVA Collaborating Grp .
DIGESTIVE AND LIVER DISEASE, 2003, 35 (06) :404-408
[5]   Survival in patients with HIV infection and viral hepatitis B or C: a cohort study [J].
Bonacini, M ;
Louie, S ;
Bzowej, N ;
Wohl, AR .
AIDS, 2004, 18 (15) :2039-2045
[6]   Methadone-maintained former heroin addicts, including those who are anti-HIV-1 seropositive, comply with and respond to hepatitis B vaccination [J].
Borg, L ;
Khuri, E ;
Wells, A ;
Melia, D ;
Bergasa, NV ;
Ho, A ;
Kreek, MJ .
ADDICTION, 1999, 94 (04) :489-493
[7]  
Chiaramonte M, 1999, CANCER-AM CANCER SOC, V85, P2132, DOI 10.1002/(SICI)1097-0142(19990515)85:10<2132::AID-CNCR6>3.3.CO
[8]  
2-8
[9]   Fulminant hepatic failure in acute hepatitis C: increased risk in chronic carriers of hepatitis B virus [J].
Chu, CM ;
Yeh, CT ;
Liaw, YF .
GUT, 1999, 45 (04) :613-617
[10]   Efficacy of granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant for hepatitis B virus in patients with HIV infection [J].
das Graças Sasaki, M ;
Foccacia, R ;
de Messias-Reason, IJ .
VACCINE, 2003, 21 (31) :4545-4549